Randal W. Scott
Director · BridgeBio Pharma, Inc.
- 2025
- May 19, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Randal W. Scott files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- Jennifer E. Cook - $21.92M in BBIO purchases and sales in the last 12 months
- Frank McCormick - $13.31M in BBIO purchases and sales in the last 12 months
- Andrew Lo - $6.32M in BBIO purchases and sales in the last 12 months
- Andrea Ellis - $5.65M in BBIO purchases and sales in the last 12 months
- Hannah Valantine - $4.37M in BBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Randal W. Scott?
Randal W. Scott is a corporate insider, tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Randal W. Scott last file a Form 4?
The most recent primary Form 4 on record is dated 19 May 2026, one of 3 filings going back to 2025.
Has Randal W. Scott been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($2.09M) across all tracked filings.
